Reduced Rapid Eye Movement Density in Parkinson Disease: A Polysomnography-Based Case-Control Study
Lynn A Schroeder1, Olivier Rufra2, Nicolas Sauvageot3
1Department of Neurosurgery, Centre Hospitalier de Luxembourg, Luxembourg-City, Luxembourg.
Sleep
|October 18, 2016
Summary
Rapid eye movement (REM) density is reduced in Parkinson
Area of Science:
- Neurology
- Sleep Medicine
- Neuroscience
Background:
- Excessive daytime sleepiness is a common symptom in idiopathic Parkinson disease (IPD).
- Current methods for assessing sleepiness in IPD may not fully capture the underlying pathophysiology.
- Rapid eye movement (REM) sleep is a critical stage of sleep, and its characteristics may be altered in neurodegenerative conditions.
Purpose of the Study:
- To investigate rapid eye movement density (RD) in patients with IPD.
- To determine if RD can serve as a surrogate marker for excessive daytime sleepiness in IPD.
- To explore the relationship between RD and other sleep parameters and subjective sleep quality in IPD patients.
Main Methods:
- A retrospective polysomnography study was conducted on 81 subjects, including early-stage IPD, middle-stage IPD, and healthy controls (HC).
- RD was calculated as the number of ocular movements per minute of REM sleep.
- Patients and controls completed validated sleepiness questionnaires, including the Parkinson's Disease Sleep Scale (PDSS) and the Nonmotor Symptoms Questionnaire (NMSQuest).
Main Results:
- RD was significantly lower in patients with IPD compared to HC, particularly in middle-stage IPD.
- Reduced RD was most pronounced in the third REM sleep episode.
- In early-stage IPD, RD showed significant correlations with subjective sleepiness scores (PDSS and NMSQuest).
Conclusions:
- REM density is reduced in patients with idiopathic Parkinson disease.
- Reduced RD correlates with subjective reports of sleep impairment and may serve as a biomarker for excessive daytime sleepiness in IPD.
- This finding suggests potential involvement of brainstem REM-generating sites in IPD and highlights RD as a promising tool for sleep research in this population.
Related Concept Videos
REM Sleep Behavior Disorder
2.3K
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
2.3K
Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Sleep-Wake Cycles
3.2K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
3.2K
Parkinson's Disease: Overview
2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Stages of Sleep
1.6K
Sleep progresses through distinct stages, each characterized by specific brain wave patterns and physiological responses ranging from wakefulness to stages of non-rapid eye movement, known as non-REM, to rapid eye movement, referred to as REM. Understanding these stages helps in recognizing how sleep supports various bodily and cognitive functions.
Before sleep begins, in wakefulness, the brain exhibits primarily beta waves, which are high in frequency and low in amplitude, indicating alertness...
Before sleep begins, in wakefulness, the brain exhibits primarily beta waves, which are high in frequency and low in amplitude, indicating alertness...
1.6K
Restless Leg Syndrome and Night Terrors
728
Restless Leg Syndrome (RLS), also known as Willis-Ekbom disease, is a neurological disorder characterized by an uncontrollable urge to move the legs due to uncomfortable sensations. These sensations typically occur during periods of rest or inactivity, particularly when lying down or sitting, and can severely disrupt sleep.
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
728


